Wave Life Sciences Ltd. (WVE)


Stock Price Forecast

April 24, 2024


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Wave Life Sciences Ltd. chart...

About the Company

Toho Co., Ltd. (東宝株式会社, Tōhō Kabushiki-gaisha) is a Japanese entertainment company primarily engaged in the production and distribution of films and the production and exhibition of stage plays. It has its headquarters in Chiyoda, Tokyo, and is one of the core companies of the Osaka-based Hankyu Hanshin Toho Group. Toho is best known for producing and distributing many of Ishirō Honda and Eiji Tsuburaya's kaiju and tokusatsu films as well as the films of Akira Kurosawa and the anime films of Studio Ghibli, CoMix Wave Films, TMS Entertainment, and OLM, Inc. The company has released the majority of the highest-grossing Japanese films, and through its subsidiaries, the company is the largest film importer in Japan. Toho's most famous creation is Godzilla, who is featured in 32 of the company's films. Godzilla, Rodan, Mothra, King Ghidorah, and Mechagodzilla are described as Toho's Big Five because of the monsters' numerous appearances throughout the franchise, as well as spin-offs. Toho has also been involved in the production of numerous anime titles. Its subdivisions are Toho-Towa Company, Limited (Japanese exclusive theatrical distributor of Universal Pictures via NBCUniversal Entertainment Japan), Towa Pictures Company Limited (Japanese exclusive theatrical distributor of Paramount Pictures), Toho Pictures Incorporated, Toho International Inc., Toho E. B. Company Limited, and Toho Music Corporation & Toho Costume Company Limited. The company is the largest shareholder (7.96%) of Fuji Media Holdings Inc. Toho is one of the four members of the Motion Picture Producers Association of Japan (MPPAJ), is the largest of Japan's Big Four film studios, and is the only film studio that is a component of the Nikkei 225 index.

Sector

Life Sciences

Industry

Pharmaceutical Preparations

Employees

298

Exchange

Nasdaq

$243M

Total Revenue

298

Employees

$597M

Market Capitalization

-9.65

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $WVE News

Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and RNA Editing

3d ago, source:

GSK has selected the first two programs to advance following achievement of target validation, marking transition to next ...

Wave Life Gains On Progress Report

3d ago, source:

This is Why Gold Could Rally All the Way to $3,000 <li /> JetBlue Outlook Drops, Share Prices With it <li /> Walmart Division ...

Wave Life Sciences Ltd. (WVE) Shares Down Despite Recent Market Volatility

8d ago, source: newsheater

Based on Wave Life Sciences Ltd. (WVE), the company’s capital structure generated 0.4 points at debt to capital in total, while cash flow to debt ratio is standing at -0.6. The debt to equity ratio ...

Wave Life Sciences Ltd. (WVE)

11d ago, source: Yahoo Finance

CAMBRIDGE, Mass., March 27, 2024 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to ...

GSK selects two programs for advancement from Wave Life Sciences collaboration

2d ago, source: BioWorld

Wave Life Sciences Ltd. has reported that GSK plc has selected its first two programs to advance to development candidates ...

Wave Life Sciences gets grant for improved method for synthesizing phosphoramidites with higher yields and purities

4d ago, source: Pharmaceutical Technology

Wave Life Sciences Ltd patent reveals a groundbreaking method for synthesizing high-purity oligonucleotides with increased yields. Learn more about this innovative process now!

Wave Life Sciences (NASDAQ: WVE)

18d ago, source: The Motley Fool

Wave Life Sciences Ltd. is a clinical-stage genetic medicines company, which engages in the development of proprietary synthetic chemistry drug. It focuses on the design, optimization, and ...

WAVE Life Sciences Ltd

22d ago, source: Morningstar

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

WAVE Life Sciences Ltd.

29d ago, source: Wall Street Journal

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

WAVE Life Sciences Ltd.

15d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...